Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

341
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
341
Varicose Veins II: Diagnostic Studies and Interprofessional Care01:26

Varicose Veins II: Diagnostic Studies and Interprofessional Care

265
Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...
265
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

601
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
601
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

432
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
432
Peripheral Artery Disease IV: Nursing Management01:26

Peripheral Artery Disease IV: Nursing Management

519
 The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
519
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

403
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
403

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HSR26-247: Real-World Quality of Life in Patients Treated With Cemiplimab for Advanced Cutaneous Squamous Cell Carcinoma: Results of CemiplimAb Survivorship Epidemiology (CASE) Study.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same author

HSR26-247: Real-World Quality of Life in Patients Treated With Cemiplimab for Advanced Cutaneous Squamous Cell Carcinoma: Results of CemiplimAb Survivorship Epidemiology (CASE) Study.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same author

Epidemiology of Eccrine Porocarcinoma in the United States: A Study of 948 Cases.

International journal of dermatology·2026
Same author

Risk of Associated Visceral Malignancies in Patients With Extra-anogenital Extramammary Paget Disease.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]·2025
Same author

Immune Checkpoint Inhibitor-Associated Squamous Cell Carcinoma: A Systematic Review.

Journal of cutaneous medicine and surgery·2025
Same author

Cancer-induced nerve injury promotes resistance to anti-PD-1 therapy.

Nature·2025
Same journal

Circulating Tumor DNA as a Biomarker for Melanoma Prognosis and Therapy.

American journal of clinical dermatology·2026
Same journal

Defining the Potential for Disease Modification in Atopic Dermatitis.

American journal of clinical dermatology·2026
Same journal

Atopic Dermatitis: New Targets and Emerging Systemic Therapies.

American journal of clinical dermatology·2026
Same journal

Rethinking Head and Neck Atopic Dermatitis: Pathogenic Axes and Emerging Therapeutic Directions.

American journal of clinical dermatology·2026
Same journal

Correction: Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program.

American journal of clinical dermatology·2026
Same journal

A Systematic Review of the Clinical Impact of GLP-1 Receptor Agonists in Hidradenitis Suppurativa.

American journal of clinical dermatology·2026
See all related articles

Related Experiment Video

Updated: Mar 9, 2026

A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis
07:22

A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis

Published on: March 14, 2025

1.3K

Stasis Dermatitis: Pathophysiology, Evaluation, and Management.

Swaminathan Sundaresan1, Michael R Migden2, Sirunya Silapunt3

  • 1University of Texas McGovern Medical School at Houston, Houston, TX, USA.

American Journal of Clinical Dermatology
|January 8, 2017
PubMed
Summary
This summary is machine-generated.

Stasis dermatitis, common in older adults, stems from venous hypertension and inflammation. Treatment ranges from compression therapy to minimally invasive procedures like endovenous thermal ablation.

More Related Videos

Deep Vein Thrombosis Induced by Stasis in Mice Monitored by High Frequency Ultrasonography
06:44

Deep Vein Thrombosis Induced by Stasis in Mice Monitored by High Frequency Ultrasonography

Published on: April 13, 2018

10.5K
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

39.6K

Related Experiment Videos

Last Updated: Mar 9, 2026

A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis
07:22

A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis

Published on: March 14, 2025

1.3K
Deep Vein Thrombosis Induced by Stasis in Mice Monitored by High Frequency Ultrasonography
06:44

Deep Vein Thrombosis Induced by Stasis in Mice Monitored by High Frequency Ultrasonography

Published on: April 13, 2018

10.5K
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

39.6K

Area of Science:

  • Dermatology
  • Vascular Medicine

Background:

  • Stasis dermatitis is a common condition in older individuals, linked to chronic venous insufficiency.
  • It results from venous hypertension caused by incompetent valves, valve destruction, or venous obstruction.
  • Inflammatory processes involving metalloproteinases, upregulated by iron from red blood cells, contribute to tissue changes.

Purpose of the Study:

  • To summarize the pathophysiology, clinical presentation, differential diagnoses, and treatment of stasis dermatitis.
  • To highlight the role of venous hypertension and inflammation in stasis dermatitis development.
  • To review diagnostic tools and evolving therapeutic strategies for stasis dermatitis.

Main Methods:

  • Literature review of stasis dermatitis, focusing on etiology, clinical findings, and management.
  • Analysis of diagnostic modalities, including duplex ultrasound for venous reflux assessment.
  • Evaluation of treatment options, from conservative compression therapy to interventional techniques.

Main Results:

  • Stasis dermatitis presents as bilateral erythematous plaques on the lower legs, often near the medial malleolus.
  • Differential diagnoses include cellulitis, contact dermatitis, and pigmented purpuric dermatoses.
  • Duplex ultrasound aids in diagnosing venous reflux when clinical presentation is ambiguous.

Conclusions:

  • Conservative management with compression therapy is the mainstay for improving venous pressure.
  • Minimally invasive interventional therapies, such as endovenous thermal ablation and foam sclerotherapy, are increasingly preferred over open surgery.
  • Effective management requires addressing the underlying venous hypertension and inflammation.